| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1905279 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2011 | 9 Pages |
AL amyloidosis is characterized by the pathologic deposition as fibrils of monoclonal light chains (i.e., Bence Jones proteins [BJPs]) in particular organs and tissues. This phenomenon has been attributed to the presence in amyloidogenic proteins of particular amino acids that cause these molecules to become unstable, as well as post-translational modifications and, in regard to the latter, we have investigated the effect of biotinylation of lysyl residues on cell binding. We utilized an experimental system designed to test if BJPs obtained from patients with AL amyloidosis or, as a control, multiple myeloma (MM), bound human fibroblasts and renal epithelial cells. As documented by fluorescence microscopy and ELISA, the amyloidogenic BJPs, as compared with MM components, bound preferentially and this reactivity increased significantly after chemical modification of their lysyl residues with sulfo-NHS-biotin. Further, based on tryptophan fluorescence and circular dichroism data, it was apparent that their conformation was altered, which we hypothesize exposed a binding site not accessible on the native protein. The results of our studies indicate that post-translational structural modifications of pathologic light chains can enhance their capacity for cellular interaction and thus may contribute to the pathogenesis of AL amyloidosis and multiple myeloma.
Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (253 K)Download as PowerPoint slideResearch Highlights►Modification of lysine residues on λ3a light chains increases their adhesion to human cells. ►Modified amyloidogenic light chains adhere to human fibroblast and epithelial cells significantly more than non-amyloidogenic light chains. ►Post-translational structural modifications of pathologic light chains enhance their capacity for cellular interaction and thus may contribute to the pathogenesis of AL amyloidosis and multiple myeloma.
